Breaking News
January 24, 2019 - Good health literacy linked to better adherence to blood pressure medications among Hispanics
January 24, 2019 - Only a minority of patients in the U.S. with type 1 diabetes achieve treatment goals
January 24, 2019 - High fat reduces efficiency of the immune system to fight infectious disease
January 24, 2019 - Study highlights need for reliable therapeutic targets for prevention, treatment of cardiovascular diseases
January 24, 2019 - Next step toward replacement therapy in type 1 diabetes
January 24, 2019 - “Scientific serendipity” identifies link between type of RNA and autism
January 24, 2019 - Trump Zeroes In On Surprise Medical Bills In White House Chat With Patients, Experts
January 24, 2019 - Unique form of chronic sinusitis found in older patients
January 24, 2019 - NUS researchers make muscle recovery easier for patients with ingenious medical device
January 24, 2019 - Specific cognitive deficits found in individuals with spinal cord injury
January 24, 2019 - An essential reference for diagnostic ultrasonography and biopsy of the thyroid gland
January 24, 2019 - Proteus Digital Health Launches Digital Oncology Medicines to Improve Patient Outcomes
January 24, 2019 - Study looking to prevent type 1 diabetes follows children into adolescence
January 24, 2019 - Nice doctors make a difference
January 23, 2019 - Blood vessel discovery could advance our knowledge of osteoporosis
January 23, 2019 - New esophageal cancer test uses genetic biomarkers to detect changes in esophagal cells
January 23, 2019 - Study evaluates first-ever Robotic Visualization System for neurosurgery
January 23, 2019 - Scientists reveal new mechanism that could lead to specific treatment of strokes and seizures
January 23, 2019 - Both educational level and occupational orientation predict mother’s smoking during pregnancy
January 23, 2019 - How to (gently) get your child to brush their teeth
January 23, 2019 - Short-term hospital readmissions for gun injuries cost $86 million a year | News Center
January 23, 2019 - New certified reference material for testing residual solvents in cannabis
January 23, 2019 - Gene-edited chickens could prevent future flu pandemic
January 23, 2019 - Cardiovascular disease risk begins even before birth
January 23, 2019 - Younger patients receiving kidney transplant more likely to live longer, shows data
January 23, 2019 - Skin samples hold early signs of prion disease, research suggests
January 23, 2019 - Researchers discover how body initiates repair mechanisms that limits damage to myelin sheath
January 23, 2019 - Fecal transplant from certain donors better than others
January 23, 2019 - Risk for Uninsurance in AMI Patients Reduced With Medicaid Expansion
January 23, 2019 - Readmissions reduction program may be associated with increase in patient-level mortality
January 23, 2019 - Fostering translation and communication in medicine and beyond
January 23, 2019 - To Fight Fatty Liver, Avoid Sugary Foods and Drinks
January 23, 2019 - TPU scientists develop new implants that double the rate of bone lengthening in kids
January 23, 2019 - New sessions at Pittcon 2019
January 23, 2019 - Insilico to present latest findings in AI for Drug Discovery at 3rd Annual SABPA FTD Forum
January 23, 2019 - Opioid overdose patients can be safely discharged an hour after administration of naloxone
January 23, 2019 - Scientists find bacterial extracellular vesicles in human blood
January 23, 2019 - Researchers use modified type of flu virus to develop new therapies for prostate cancer
January 23, 2019 - Researchers gain new insights into development of necrotizing enterocolitis in preemies
January 23, 2019 - Medical expert advises people with epilepsy not to stockpile medicines
January 23, 2019 - CDC study explores link between smoking and clinical outcomes of assisted reproductive technology
January 23, 2019 - Study outlines research priorities for improving pediatric patient care and safety
January 23, 2019 - Bedfont to exhibit NObreath FeNO monitor at Arab Health 2019
January 23, 2019 - Nicotinamide riboside supplementation confers significant physiological benefits to mothers and offspring
January 23, 2019 - Increasing temperatures may help preserve crop nutrition
January 23, 2019 - Many Oncologists in the Dark About LGBTQ Health Needs
January 23, 2019 - Epigenetic change causes fruit fly babies to inherit diet-induced heart disease
January 23, 2019 - Erasing memories could reduce relapse rates among drug addicts
January 23, 2019 - African Americans who smoke cigarettes are more likely to develop peripheral artery disease
January 23, 2019 - Unique data combination helps FinnGen researchers to fund links between genetic factors and health
January 23, 2019 - Parents’ mental health problems associated with reactive attachment disorder in children
January 23, 2019 - Graphene Flagship project studies impact of graphene and related materials on our health
January 23, 2019 - The connection between the Pope and contraceptive pills
January 23, 2019 - Prior dengue infection could protect children from symptomatic Zika
January 23, 2019 - Previous dengue virus infection associated with protection from symptomatic Zika
January 23, 2019 - VISTA checkpoint implicated in pancreatic cancer immunotherapy resistance
January 23, 2019 - The Tiny Camera That Could Revolutionize Cardiovascular Surgery
January 23, 2019 - Peptide isolated from soil fungi has antitumor and antibacterial properties
January 23, 2019 - TGen identifies polio-like virus as potential cause of Acute Flaccid Myelitis outbreak
January 23, 2019 - Migrants and refugees do not bring disease and are at greater health risk themselves says WHO
January 23, 2019 - Examing the effects of menopause in workplace
January 23, 2019 - Enemy number 1 – Air pollution and climate change top of WHO agenda
January 23, 2019 - Two Positive Phase III studies of Tafenoquine for the Radical Cure of Plasmodium vivax Malaria Published in The New England Journal of Medicine
January 23, 2019 - World Trade Center responders at increased risk for head and neck cancers
January 23, 2019 - Low-sugar diet leads to significant improvement in nonalcoholic fatty liver disease in boys
January 23, 2019 - Chaos in bodily regulation can optimize our immune system, finds study
January 23, 2019 - Short, text-based exercises can increase happiness for adults recovering from substance use disorders
January 23, 2019 - Body size may have greater influence on women’s lifespan than men
January 23, 2019 - Groundbreaking tool helps visualize neuronal activity with near-infrared light
January 23, 2019 - Prior dengue immunity in children may be protective against symptomatic Zika
January 23, 2019 - Holocaust survivors with PTSD and their offspring exhibit more unhealthy behavior patterns
January 23, 2019 - Scientists discover new genetic mutations causing inherited deaf-blindness
January 23, 2019 - UC team designs new naloxone-dispensing smart device
January 23, 2019 - Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP
January 23, 2019 - Brain activity shows development of visual sensitivity in autism
January 23, 2019 - Two hour gap between dinner and sleep is overrated says Japanese research
January 23, 2019 - Fear and embarrassment are causing smear test numbers to plummet
January 23, 2019 - Protein-secreting device implanted in epileptic rats reduces seizures, improves cognition
January 23, 2019 - Reintroduction project recovers current wild population of green turtle in Cayman Islands
January 23, 2019 - Cancer survivors face greater financial burden related to medical bills
Study reveals how Seneca Valley Virus interacts with tumor receptors

Study reveals how Seneca Valley Virus interacts with tumor receptors

image_pdfDownload PDFimage_print

Seneca Valley Virus sounds like the last bug you’d want to catch, but it could be the next breakthrough cancer therapy. Now, scientists at the Okinawa Institute of Science and Technology (OIST) and the University of Otago have described exactly how the virus interacts with tumors — and why it leaves healthy tissues alone.

A cryo-EM map of the receptor decorated capsid in which a single protomer was replaced with the atomic model. Seneca Valley Virus capsid proteins are shown in blue, green, and red, and the ANTXR1 receptor is shown in magenta. Credit: OIST and University of Otago

The study, published in the Proceedings of the National Academy of Sciences of the United States of America on October 29, 2018, provides the first detailed images of the complex Seneca Valley Virus forms with its preferred receptor. The researchers used cryo-electron microscopy to capture images of over 7000 particles and render the structure in high-resolution. They predict their results will help scientists develop the virus, and other viral drug candidates, for clinical use.

“If you have a virus that targets cancer cells and nothing else, that’s the ultimate cancer fighting tool,” said Prof. Matthias Wolf, principal investigator of the Molecular Cryo-Electron Microscopy Unit at OIST and co-senior author of the study. “I expect this study will lead to efforts to design viruses for cancer therapy.”

Targeting two-thirds of human cancers

In the past few years, so-called “virotherapy” has grown up as a new branch of cancer immunotherapy. Anticancer viruses tend to target tumors while sparing the healthy cells around them, and many already exist in nature. Scientists hunt down these cancer-killers, study their attack strategies, and optimize their effectiveness through genetic modification. The U.S. Food and Drug Administration has already approved one viral therapy to treat Stage IV melanoma, and other viral drug candidates appear promising in clinical trials.

Seneca Valley Virus stands out as a potential virotherapy for one key reason: it selectively targets a receptor found coating tumor cells in over 60 percent of human cancers. The receptor, known as ANTXR1, is only expressed on tumors, but it has a cousin that only appears on healthy tissues, called ANTXR2. Seneca Valley Virus doesn’t bind with the similar receptor on healthy cells — it only shows strong affinity for ANTXR1. The study’s authors wanted to know why.

“The differences between the two receptors are subtle, but nonetheless, these subtle differences make one bind the virus with high affinity while the other doesn’t,” said Wolf. The researchers found that the outer shell of the Seneca Valley Virus locks tightly onto specific structural features of ANTXR1 — features that aren’t conserved in ANTXR2. “The components must fit together like a key in a lock — this is a highly evolved system where everything fits perfectly.”

Designing an optimal cancer therapy

Seneca Valley Virus has already demonstrated its cancer-fighting abilities in Phase I clinical trials in pediatric solid tumors and Phase II trials in small-cell lung cancers. But there’s one problem: the body builds up immunity to the virus within three weeks and squashes the bug before its work is done.

“If you give a virus as a vaccine, you want an immune response — there, the goal is the destruction of the virus,” said Wolf. “In this case, you want the opposite. You want the virus to evade the immune system, continue to replicate and kill the cancer cells.”

“By looking at this structure, we can learn what part of the virus is essential for binding to the receptor and which is not,” said Prof. Mihnea Bostina, the academic director of the Otago Centre for Electron Microscopy at the University of Otago and co-senior author of the study. “If we want to make the virus ‘better,’ we can try to change the non-essential parts in order to escape the action of the immune system while leaving the essential part intact.”

With deeper understanding of how the virus works, scientists may be able to outsmart the body’s immune system and protect their mighty cancer-killer. In principle, Seneca Valley Virus could also be modified to recognize different receptors, Wolf said, rendering it a broadly applicable weapon in the fight against cancer.

“I have always been intrigued by ways how we can make use of naturally occurring microorganisms for our benefit,” said Nadishka Jayawardena, a graduate student at the University of Otago and first author of the study. “Being able to work on a virus that can kill cancers is very rewarding, especially knowing that one day our findings could potentially lead to tackling a major global health issue.”

The Seneca Valley Virus at Near-Atomic Resolution

Source:

https://www.oist.jp/news-center/press-releases/anti-cancer-virus-fits-tumor-receptor-%E2%80%9Ckey-lock%E2%80%9D

Tagged with:

About author

Related Articles